Based on the previous studies and the present study, we suggest that the effect of ivabradine on myocardial fibrosis is related to the reduction of the proinflammatory cytokines TNF-α, IL-1β, and IL-6. This evidence concerns the gene IL6 and Myocardial fibrosis.